Natus welcomes Optima Medical to the Natus family of solutions
The shareholders of Optima Medical Limited have sold the company to Natus Medical Incorporated.
Optima Medical is one of the UK and Ireland’s leading supplier of neurodiagnostic equipment and accessories (EEG, Sleep, EMG, IOM). Since it was founded in 1999, Optima has installed thousands of systems in hospitals throughout the UK and Ireland. The company has built its reputation through supplying high-performance equipment combined with technical and clinical expertise. Its team consists of highly experienced engineers, product experts and clinical specialists trained and qualified to support customers throughout the life of their equipment.
Natus delivers solutions to screen, diagnose and treat disorders affecting the brain, neural pathways and eight sensory nervous systems, its aim being to advance the standard of care and improve patient outcomes and quality of life. Natus offers hardware, advanced software and algorithms, and consumables that provide stimulus, acquire and monitor physiological signals, and capture the body’s response. With sales in over 100 countries, Natus is a global leader in neurodiagnostics.
With a long-standing history as a trusted distribution partner of Natus Medical, the acquisition of Optima signifies a significant step forward, elevating their already successful partnership to a new phase. Together, they are able to enhance their shared goal of providing industry leading products and exceptional customer support, bringing it closer to their customers within the British Isles.
Oaklins Evelyn Partners, based in the UK, acted as lead advisor to the shareholders of Optima.
Talk to the deal team
Related deals
Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.
Learn moreGroupe JVS has completed an LBO with Capza and Bpifrance
The shareholders of Groupe JVS have completed an LBO with Capza and BpiFrance. Parquest sold their shares after partnering with the organization for three years. Groupe JVS’s management team will increase its ownership and remain as the majority shareholder of the group, alongside CAPZA and Bpifrance.
Learn moreCreo Medical Group plc has completed a US$15.7 million equity fundraise
Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.
Learn more